FDAnews
www.fdanews.com/articles/120160-roche-europe-approves-drug-for-advanced-leukaemia

Roche: Europe Approves Drug for Advanced Leukaemia

September 3, 2009
The European Commission has approved Roche Holding AG’s MabThera cancer drug to treat patients whose chronic lymphocytic leukaemia returns, the Swiss drugmaker said.
Forbes